Gyre Therapeutics Inc. Cash Flow Reinvestment Rate
Gyre Therapeutics Inc. cash flow reinvestment rate. Gyre Therapeutics Inc. (GYRE) has a Cash Flow Reinvestment Rate of 0.96x as of March 2026, reinvesting $3.06 Million (capex $178.00K plus investments $-2.88 Million) from operating cash flow of $3.18 Million. Explore GYRE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Gyre Therapeutics Inc. (2007–2025)
Cash flow reinvestment rate of Gyre Therapeutics Inc. from 2007 to 2025. Historical reinvestment intensity for Gyre Therapeutics Inc. across 5 annual periods. Explore reinvestment intensity of Gyre Therapeutics Inc. to see what proportion of operating cash flow is directed to capital expenditures.
Gyre Therapeutics Inc. Cash Flow Reinvestment Rate by Year (2007–2025)
Gyre Therapeutics Inc. cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Gyre Therapeutics Inc.. For the full cash flow conversion analysis, see GYRE operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.58x | $2.61 Million | $1.01 Million | $1.19 Million | ▲ +136.0% |
| 2023 | 1.09x | $28.35 Million | $25.89 Million | $8.59 Million | ▼ -37.9% |
| 2022 | 1.76x | $18.81 Million | $10.68 Million | $5.00 Million | ▲ +7259.4% |
| 2010 | 0.02x | $3.31 Million | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $4.94 Million | $24.84 Million | $4.94 Million | — |